Bracco Gains FDA Clearance for VueJect Cardiac Imaging System
MILAN, Italy, August 11, 2026 Bracco Imaging has announced that its VueJect® ultrasound contrast delivery system has received 510(k)...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MILAN, Italy, August 11, 2026 Bracco Imaging has announced that its VueJect® ultrasound contrast delivery system has received 510(k)...
BOLOGNA AND MILAN, Italy, August 13, 2026 Alfasigma S.p.A. has entered into a share purchase agreement with SEVER Life...
KIRKLAND, Québec, Canada, July 29, 2026 Pfizer Canada ULC announced that PREVNAR 20™, its 20-valent pneumococcal conjugate vaccine, has...
BURLINGTON, Mass., July 6, 2026 PharmaEssentia Corporation announced that its wholly owned Canadian subsidiary, FORUS Therapeutics Inc., has received...
NEW YORK, June 29, 2026 DarioHealth Corp. has announced a strategic collaboration with Beluga Health to create a provider-backed,...
NEW YORK & WESTFIELD, N.J., June 29, 2026 Talawar Therapeutics has announced a definitive business combination agreement with JATT...
KIRKLAND, Quebec, Canada & SHANGHAI, China, June 23, 2026 Organon Canada and Shanghai Henlius Biotech have expanded access to...
WINNIPEG, Manitoba – February 26, 2026 Emergent BioSolutions (NYSE: EBS) has announced approximately $140 million CAD in multiyear contract...
